// App-Quantinova.ai

321 : Pharmacotherapy for VAD Thrombus: Response Rates and Financial Impact of Anticoagulant Strategies

Researchers

Presenter

  • Lynne Sylvia

Principal Investigators

  • Frank Massaro

  • David DeNofrio

  • Michael Kiernan

Medical Centers

  • Tufts Medical Center, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

  • eptifibatide

  • Bivalirudin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved